Tempest Therapeutics, Inc. (TPST) Misses Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts TPST Hot Sheet
Join SI Premium – FREE
Tempest Therapeutics, Inc. (NASDAQ: TPST) reported Q3 EPS of ($0.41), $0.05 worse than the analyst estimate of ($0.36).
For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
- William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
- Wealthfront launches custodial account with tax-gain harvesting
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
